Clinical and Translational Science Award (UM1 Clinical Trial Optional)
ID: 335022Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/335022

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-293.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Clinical and Translational Science Award (UM1 Clinical Trial Optional), aimed at establishing hubs within the Clinical and Translational Science Award (CTSA) Program. The primary objectives of this funding opportunity are to enhance the efficiency of clinical research, foster collaborations among diverse institutions, and address health disparities through innovative scientific and operational practices. These hubs will play a vital role in advancing translational science by developing resources, conducting pilot projects, and engaging with underserved communities, while adhering to Good Clinical Practice guidelines. Interested applicants must submit their proposals by September 13, 2024, and are required to include a companion K12 Clinical Scientist Institutional Career Development Program application for their submission to be reviewed. For further details, applicants can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-293.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-21-293-Full-Announcement.html
    PAR-21-293.html
    The Clinical and Translational Science Award (UM1 Clinical Trial Optional) funding opportunity, led by the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS), invites applications for CTSA Program hubs aimed at accelerating clinical and translational research. The program's objectives are to enhance research efficiency, promote collaboration, and address health disparities through innovative science and training frameworks. Key aspects include the requirement for partnerships among diverse institutions, with all applications needing to incorporate a mandatory K12 Career Development Program. Hubs play a crucial role in fostering translational science by developing resources, conducting pilot projects, and engaging stakeholders, particularly from underserved communities. The funding tier structure ensures financial support is proportionate to institutional NIH funding, with a maximum budget determined by the applicant's past NIH direct costs. CTSA hubs are expected to demonstrate commitment to diversity, patient engagement, and continuous quality improvement while adhering to Good Clinical Practice guidelines. The program emphasizes a collaborative approach to tackle systemic challenges in clinical research, ultimately aimed at transforming health outcomes and improving efficiencies in translational research. Applications must comply with detailed submission guidelines to ensure review and funding consideration.
    Similar Opportunities
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition Funding Opportunity titled "High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development of unique capabilities and resources to address critical gaps in clinical and translational science within awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs. The funding opportunity, numbered PAR-25-156, allows for project budgets of up to $500,000 per year over a project period of up to five years, with applications involving clinical trials being optional. Interested applicants, primarily from public and state-controlled institutions of higher education, must submit detailed integration plans, milestones, and sustainability evaluations by the closing date of September 28, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development and demonstration of innovative resources and capabilities within Clinical and Translational Science Awards (CTSA) Program hubs, specifically targeting critical gaps and roadblocks in clinical research. Successful applicants, who must be active UM1 CTSA award recipients, will propose projects lasting up to five years with an annual budget cap of $500,000, emphasizing collaboration and innovation in health research. Interested parties should note that the application deadline is September 14, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Clinical and Translational Science Award (CTSA) Program, aimed at establishing hubs that will contribute to a national consortium focused on accelerating the delivery of treatments to patients through advancements in clinical and translational science. This initiative is designed to foster meaningful collaborations and responsive projects among eligible applicants, which include various organizations and institutions. The anticipated NOFO is expected to be published in Summer 2024, with applications due by January 2025, and the estimated award date is set for December 16, 2025. Interested parties should prepare for the upcoming application process as no cost-sharing or matching is required for this cooperative agreement funding opportunity.
    Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Limited Competition funding opportunity titled the Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research through collaborative efforts among multiple medical research institutions. This initiative seeks to support the development, implementation, and dissemination of innovative solutions that address urgent public health needs and promote health equity, requiring applicants to include at least three eligible organizations to foster interdisciplinary partnerships. Eligible projects can receive funding of up to $650,000 annually for a total duration of up to five years, with applications due by October 19, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-296.html.
    Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a limited competition grant opportunity for the Mentored Research Career Development Program Award under the Clinical and Translational Science Awards (CTSA) Program. This initiative aims to develop innovative career advancement programs for later-stage postdoctoral fellows and junior faculty who are committed to independent clinical and translational science research careers, facilitating their transition into leadership roles through structured mentorship and research experiences. The program is designed to enhance the clinical and translational science workforce, addressing national biomedical research needs, and encourages diversity among scholars. Eligible institutions may submit a single K12 application alongside a UM1 application, with a funding period of up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov, with the application deadline set for September 28, 2027.
    Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to re-issue the Notice of Funding Opportunity Announcement (PAR-22-167) for the Clinical and Translational Science Award (CTSA) Program, specifically the Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). This funding opportunity aims to foster meaningful collaborations and innovative projects in clinical and translational science, with no cost-sharing or matching requirements for eligible applicants, which include for-profit organizations. The estimated total program funding is $5 million, with an award ceiling of $650,000, and the NOFO is expected to be published in Fall 2024, with applications due in Winter 2025. Interested parties should prepare for the anticipated timeline, as the estimated project start date is December 1, 2025, and further details can be found on the CCIA webpage.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program, designated as R03 Clinical Trial Optional. This funding opportunity aims to support KL2/K12 scholars and recipients of diversity and re-entry supplements in their transition to independent research roles by funding small, innovative, self-contained projects in translational science, with a maximum budget of $50,000 per year over a two-year period. The initiative is designed to enhance the capabilities of emerging researchers in addressing inefficiencies in translating research into clinical applications, engaging underrepresented populations, and improving data accessibility through innovative technologies. Applications will be accepted starting January 19, 2024, with multiple deadlines leading up to October 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Center for Advancing Translational Sciences (NCATS), has announced a funding opportunity for the Limited Competition Small Grant Program (R03), aimed at supporting Clinical and Translational Science Award (CTSA) Program KL2/K12 scholars and diversity supplement recipients. This program is designed to facilitate the transition of these scholars to independent research careers by funding small, self-contained research projects that can be conducted quickly and with limited resources, ultimately addressing inefficiencies in translational science. Grants of up to $50,000 per year are available for projects lasting up to two years, with a submission deadline of January 17, 2025, and an anticipated award cycle beginning in February 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program. This grant aims to support eligible institutions in creating and disseminating training programs for PhD students in clinical and translational science, with a focus on developing a diverse pool of trainees equipped with the necessary skills to address public health needs. The program emphasizes institutional commitment, mentorship, and innovative training strategies, while excluding combined predoctoral and postdoctoral training and independent clinical trials. Interested institutions must submit their applications by September 28, 2027, and can find further details and contact information at grantsinfo@nih.gov or through the provided link to the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-194.html.
    IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional) to enhance clinical and translational research capabilities in IDeA-eligible states. This funding opportunity aims to strengthen workforce development and improve infrastructure in health research organizations that typically have limited capacities for such research, with a focus on building research capacity and fostering collaboration within the community. Each organization can submit one application with a budget not exceeding $1.5 million over a maximum project period of five years, and successful applicants must address various cores including Administrative, Professional Development, Community Engagement, Research Design/Compliance, and Health Research, while also emphasizing diversity and inclusion in research. Interested applicants can find more information and submit their applications through the NIH ASSIST system or Grants.gov, with the application deadline set for October 9, 2025.